BridgeMD
Tests treatment safety and results for Contraceptive Usage
Official title Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
ClinicalTrials.gov ID: NCT05674513
What this study is testing
What is Ulipristal acetate?
Ulipristal acetate is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for contraceptive usage.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to learn more about why some people are at greater risk for oral emergency contraceptive failure while others are not. The investigators want to learn if genetic differences impact the risk of emergency contraception failure.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only. Healthy volunteers may be eligible.
You may be able to join if
- Generally healthy women
- Aged 18-40
- regular menses (every 21-35 days) experiencing ovulatory cycles proven by a single progesterone level of 3 ng/mL or greater during the luteal phase...
You likely can't join if
- Pregnant, seeking pregnancy, or breastfeeding
- Known allergy to study medication
- Recent use of hormonal contraception
- Irregular periods (\ 35 day cycles)
- Routine use of nonsteroidal anti-inflammatory drugs
- Metabolic disorders
See the full eligibility criteria
- Generally healthy women
- Aged 18-40
- regular menses (every 21-35 days) experiencing ovulatory cycles proven by a single progesterone level of 3 ng/mL or greater during the luteal phase of the screening cycle.
- Pregnant, seeking pregnancy, or breastfeeding
- Known allergy to study medication
- Recent use of hormonal contraception
- Irregular periods (\ 35 day cycles)
- Routine use of nonsteroidal anti-inflammatory drugs
- Metabolic disorders
- Smoking
- Any condition that would preclude the provision of informed consent
- Using drugs (within 2 weeks of study enrollment) known to interfere with the metabolism of UPA as well as drugs known to be CYP3A4 inducers, inhibitors, or CYP3A drug substrates
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.